Aurinia Pharmaceuticals Inc. 4 filing

Filed 2026-02-23 · Report date 2026-02-20 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001746372-26-000002
Form type: 4
CIK: 0001600620
Primary document: https://www.sec.gov/Archives/edgar/data/1600620/000174637226000002/xslF345X05/wk-form4_1771880754.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Aurinia Pharmaceuticals Inc..

Reported financial metrics

Metric	Current	Prior	Change